1.40
+0.045(+3.33%)
Currency In USD
Address
919 East Hillsdale Boulevard
Foster City, CA 94404
United States of America
Phone
650 473 7700
Website
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Employees
229
First IPO Date
January 29, 2018
| Name | Title | Pay | Year Born |
| Harout Semerjian | Chief Executive Officer, President & Director | 0 | 1970 |
| Joseph Emile Eid | Executive VP of Research & Development and Chief Medical Officer | 304,098 | 1967 |
| Scott Samuels | Executive VP, Chief Legal Officer & Secretary | 485,317 | N/A |
| Michelle J. Robertson | Executive VP, CFO, Treasurer and Principal Financial & Accounting Officer | 846,376 | 1967 |
| Ahmed ElNawawi | Executive VP & Chief Commercial Officer | 0 | N/A |
| Bryan Ridgell | Senior Vice President of Portfolio & Project Management and Chief of Staff | 0 | N/A |
| Shanthakumar Tyavanagimatt | Senior VP & Chief Technical Officer | 0 | N/A |
| Aron Feingold | Vice President of Investor Relations & Corporate Communications | 0 | N/A |
| Dawn Schottlandt | Senior Vice President of Investor Relations & Corporate Affairs | 0 | N/A |
| Shannon Odam | Executive VP & Chief People Officer | 0 | 1975 |
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.
